UPM-Kymmene Oyj banner

UPM-Kymmene Oyj
F:RPL0

Watchlist Manager
UPM-Kymmene Oyj Logo
UPM-Kymmene Oyj
F:RPL0
Watchlist
Price: 25 EUR Market Closed
Market Cap: €13.2B

Wall St Price Targets

RPL0 Price Targets Summary
UPM-Kymmene Oyj

Wall Street analysts forecast RPL0 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RPL0 is 28.24 EUR with a low forecast of 21.98 EUR and a high forecast of 34.83 EUR.

Lowest Forecast
Price Target
21.98 EUR
12% Downside
Average Forecast
Price Target
28.24 EUR
13% Upside
Highest Forecast
Price Target
34.83 EUR
39% Upside
UPM-Kymmene Oyj Competitors:
Price Targets
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
35% Upside

Revenue
Forecast

0% / Year
Past Growth
2% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
0% / Year
Past Growth
2% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is 2%.

Gross Profit
Forecast

-1% / Year
Past Growth
-45% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-1% / Year
Past Growth
-45% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been -1%. The projected CAGR for the next 1 year is -45%.

Operating Income
Forecast

3% / Year
Past Growth
38% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
3% / Year
Past Growth
38% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is 38%.

Pre-Tax Income
Forecast

4% / Year
Past Growth
26% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
4% / Year
Past Growth
26% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 26%.

Net Income
Forecast

0% / Year
Past Growth
33% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
0% / Year
Past Growth
33% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is 33%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RPL0's stock price target?
Price Target
28.24 EUR

According to Wall Street analysts, the average 1-year price target for RPL0 is 28.24 EUR with a low forecast of 21.98 EUR and a high forecast of 34.83 EUR.

What is the Revenue forecast for UPM-Kymmene Oyj?
Projected CAGR
2%

Over the last 14 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is 2%.

What is the Gross Profit forecast for UPM-Kymmene Oyj?
Projected CAGR
-45%

Over the last 14 years, the compound annual growth rate for Gross Profit has been -1%. The projected CAGR for the next 1 year is -45%.

What is the Operating Income forecast for UPM-Kymmene Oyj?
Projected CAGR
38%

Over the last 14 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is 38%.

What is the Pre-Tax Income forecast for UPM-Kymmene Oyj?
Projected CAGR
26%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 26%.

What is the Net Income forecast for UPM-Kymmene Oyj?
Projected CAGR
33%

Over the last 14 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is 33%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett